RCP - Key Persons
As owner of FDA Regulatory, LLC, Andy is experienced in all aspects of U.S. regulatory affairs and FDA interactions. He has been an active and highly respected member of the regulatory community for decades and has personally led over 100 meetings with the FDA, managed multi-site global regulatory teams for both large and small pharma, and led preparations and presentations to FDA Advisory Committees with successful outcomes. Of note, Andy was the first industry representative invited to speak at the FDA Project Manager Forum.
Christina is a multifaceted biotech executive with expertise in global commercialization, medical communications and rare disease. Adept at building high-performance teams that drive value across an organization, Christina is deeply inspired to create a legacy of innovation by changing the approach to commercialization, improving rates of success and impacting the lives of patients worldwide.
Christina J. Ansted, MPH, CCMEP is a dynamic, results-driven, and entrepreneurial biotechnology executive dedicated to building a legacy of innovation for how clinical-stage biotech companies approach commercialization, improving rates of success and to making a difference for patients living with rare or poorly managed disease.
Christina has extensive experience in the global commercialization of rare disease products, medical services, and medical communications with expertise in patient identification and diagnostic strategy. She is a solution-oriented leader, highly focused on optimization, outcomes, and driving value across an organization with a sophisticated approach to commercialization strategy and execution and building high performance teams.
Job Titles:
- Chief of Staff
- Coordinator, Global Shared Medical Services at PTC Therapeutics, Inc
"Christina's acumen in the pharmaceutical industry truly does speak for itself; she is a dynamic force within the industry. One aspect of her leadership is her uncanny ability to build a team in the truest sense of the term. Everybody who worked on her team within GSMS felt like he/she was part of something greater than any individual. We worked with and for each other. It was Christina's day-to-day diligence in making sure that each of us knew what we needed to do and had the resources to accomplish it that sustained our dedication to her. Her genuine warmth carried through to all of us."
Job Titles:
- VP, Global Pricing & Payer Insights
Jennifer brings a wealth of commercial and market access experience across oncology and orphan drugs. She is well-versed in global, EMEA and Asia Pacific/Japan markets supporting pricing and market access strategies in both strategic development and implementation with the goal of achieving optimal access for all stakeholders.
Job Titles:
- Public Relations & Communications
Founder and President at Pilcrow Grou p, Kelly is an award-winning communications and public relations leader with extensive experience creating and executing strategic communications plans that drive engagement and visibility. She has a proven track record of building and leading high-performing teams and is passionate about helping companies tell their stories.
Kevin's extensive expertise in market access, pricing and reimbursement, HEOR, health policy and government affairs, and patient/medical advocacy enables him to maximize global revenue potential and market share growth. he leads patient and market access strategy and implementation.
Mark has led commercialization efforts in large pharma, startup biotech and medical device companies and across a range of therapeutic areas including GI, Immunology, Derm, Pain, Infectious Diseases, Neuro and Rare Diseases. His focus is on bringing market insights into a development-stage program to ensure that the team is asking and answering the right questions to set the product up for future US and Global commercial success. He has led a number of launches and enjoys leading cross-functional teams at both a strategic and operational level.
Job Titles:
- Co - Founder and CRO / Head, Private Market Practice
Michael has led global teams focused on global business development, private equity, sales operations, training and development, and business process optimization. With a commitment to outcomes and outstanding relationship management, Michael's vision is to drive value creation for private market clients with biotech centric portfolios.
Paresh is a board-certified internist and gastroenterologist with hepatology expertise and broad medical/scientific and corporate management experience having led clinical development programs, and global multidisciplinary teams across the development spectrum, with a proven record of multiple successful NDAs.
Job Titles:
- VP, US Practice Lead Market Access
Rob is a seasoned pharmaceutical executive with diverse and progressive experience in sales and market access. He helps clients navigate the complex and competitive U.S. payer landscape to optimize patient access and revenue potential. With a focus on the patient, Rob has successfully developed and executed national access strategies for major payers, PBMs, and government programs, resulting in significant market share and sales growth for innovative products.
CEO of CILA Therapeutics, Safia is a life science business executive and entrepreneur with more than 20 years of experience in all aspects of the biotech/pharma value chain, from discovery to commercialization. A former computational biologist with a deep understanding of AI data, informatics, clinical trials and market access, she is highly skilled at transitioning scientific concepts into product pipelines and has served as a strategic advisory for biopharma CEOs and leadership teams.
Steve brings over 30 years of corporate experience, including more than 15 years in senior leadership roles. Beginning his career as an auditor in the Big 4, Steve has held CFO and other senior executive positions across various industries and ownership structures. As a partner at LGA, Steve leads the firm's fractional CFO practice. Along with LGA, he offers a broader suite of financial and advisory services, including audit, tax, business valuation and outsourced accounting, ensuring comprehensive support for RCP clients.
Terry is a seasoned and respected biopharma veteran bringing 25 years of unique cross functional experience across Medical Affairs, Commercial, and Diagnostic Strategy specializing in rare and ultra-rare diseases. Recognized for his collaborative approach, he is adept in aligning medical affairs and commercial strategy to facilitate successful product launches. Terry has led medical affairs and field sales teams in multiple biopharma companies from large & mid cap to privately held biotech startups.
Tom has exceptional experience expanding the treatable patient population for therapeutics. With a focus on building awareness for diagnostic testing to enable optimal patient identification and timely therapy, Tom has led diagnostic strategy for eight rare diseases and provided leadership to develop and implement diagnostic strategy supporting field implementation and training across a myriad of therapeutic areas. He applies his considerable field sales acumen to ensure successful collaboration, integration, and execution of strategic diagnostic initiatives.